NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy

Diabetic Medicine

Volumn 14, Issue 4, 1997, Pages 284-290

  Pitei, D L ^a   Watkins, P J ^a   Edmonds, M E ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

diabetic peripheral sensory neuropathy; endothelium dependent and endothelium independent vasodilatation; iontophoresis; vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; INSULIN; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENDOTHELIUM; FEMALE; FOOT; HUMAN; HUMAN EXPERIMENT; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; VASODILATATION;

ACETYLCHOLINE; ADULT; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NITRIC OXIDE; NITROPRUSSIDE; VASODILATION; VASODILATOR AGENTS;

EID: 0030996590     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199704)14:4<284::AID-DIA348>3.0.CO;2-0     Document Type: Article

References (44)

1. Burnstock G, Ralevic V. New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 1994; 47: 527-543.
2. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localised in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neurone 1991; 7: 615-624.
3. Vallance P, Moncada S. Nitric oxide - from mediator to medicines. J R Coll Physicians Lond 1994; 28: 209-219.
4. Rand MJ, Li CG. Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission. Annu Rev Physiol 1995; 57: 659-682.
5. Forst T, Kann P, Pfutzner A, Lobmann R, Schafer H, Beyer J. Association between diabetic thick skin syndrome and neurological disorders in diabetes mellitus. Acta Diabetol 1994; 31: 73-77.
6. Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995; 38: 1337-1344.
7. Westerman RA, Widdop RE, Hannaford J, Low A, Roberts RGD, Keny P, et al. Laser Doppler velocimetry in the measurement of neurovascular function. Australas. Phys & Eng Sci in Med 1988; 11: 53-64.
8. Gardner-Medwin JMM, MacDonald IA. Reduced vasodilatation to acetyl-choline in the finger microcirculation in primary Raynaud's phenomenon. Br J Rheumatology 1995; 34:25.
9. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986; 131: 75-78.
10. Meraji S, Jayakody L, Rajjote R, Senaratne MP, Thompson ABR, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 1987; 36: 978-981.
11. Porta M, Le Salva M, Molinatti P, Molinatti GM. In vivo studies of Von Willebrand factor and other endothelial molecules in diabetic microangiopathy. In: Mollinatti GM, Bar RS, Belfiore F, Porta M, eds. Endothelial Cell Function in Diabetic Microangiopathy; Problems in Methodology and Clinical Aspects, vol. 9. New York: Karger, 1990: 56-63.
12. Tooke JE. Microvascular haemodinamics in diabetes mellitus. Clin Sci 1986; 70: 119-125.
13. Saenz de Tejada I, Goldstein I, Azadzoi KM, Krane R, Cohen R. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025-1030.
14. Elliot TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993; 85: 687-693.
15. McVeigh G, Brennan G, Johnston D, et al. Impaired endothelium-dependent and independent vasodilatation in patients with type 2 diabetes. Diabetologia 1992; 35: 771-776.
16. Calver A, Collier J, Vallance P. Inhibition and stimulation of NO synthesis in the human forearm arterial bed of patients with IDDM. J Clin Invest 1992; 90: 2548-2554.
17. Kiff RJ, Gardiner SM, Compton AM, Bennett T. The effect of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 1991; 103: 1311-1326.
18. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol 1989; H621-H625.
19. Vracko R, Benditt EP. Capillary basal lamina thickening. Its relationship to endothelial cell death and replacement. J Cell Biol 1970; 47: 281-285.
20. Jaap AJ, Shore AC, Tooke JE. Diminished endothelium-dependent microvascular vasodilatation in subjects with impaired glucose tolerance. Diabetic Med 1994; 11-(suppl 2): S22.
21. Pieper-GM, Peltier-BA. Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J Cardiovasc Pharmacol 1995; 25: 397-403.
22. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein-kinase C. J Clin Invest 1991; 87: 1643-1648.
23. Bucala R, Tracey J, Cerami A. Advanced glycosylation products quench NO and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991; 87: 432-438.
24. Lash JM, Bohlen HG. Structural and functional origins of suppressed acetylcholine vasodilatation in diabetic rat arterioles. Circ Res 1991; 69: 1259-1268.
25. Houben AJHM, Schaper NC, Haan CHA, Huvers FC, Slaaf DW, de Leeuw PW, Nieuwenhuijzen Kruseman AC. The effects of 7-hour local hyperglycaemia on forearm macro and microcirculatory blood flow and vascular reactivity in healthy man. Diabetologia 1994; 37: 750-756.
26. Smits P, Kapma J, Jacobs M, Lutterman J, Thien T. Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes 1993; 42: 148-153.
27. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilatation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 771-776.
28. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med 1988; 318: 1206-1309.
29. Walmsley D, Wiles PG. Early loss of neurogenic inflammation in the human diabetic foot. Clin Sci Colch 1991; 80: 605-610.
30. Kihara M, Low PA. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 1995; 132: 180-185.
31. Bredt D, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature (Lond). 1990; 347: 768-770.
32. Gorsky LD, Forstermann U, Ishii K, Murad F. Production of an EDRF-like activity in the cytosol of N1E-115 neuroblastoma cells. Fed Am Soc Exp Biol J 1990; 4: 1494-1500.
33. Garthwaite J, Charles SL, Chess-Williams R. EDRF release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (London) 1988; 336: 385-388.
34. Kim M, Azadzoi KM, Goldstein I, Saenz de Tejada I. A NO-like factor mediates noradrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 112-118.
35. Gibson A, Mirzazadeh S, Hobbs AJ, Moore PK. L-Ng-Monomethyl arginine and L-Ng-nitro-arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br J Pharmacol 1990; 99: 602-606.
36. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG. NO as an inhibitory non-adrenergic, non-cholinergic neurotransmitter. Nature (London) 1990; 345: 346-347.
37. Coffman JD. Effects of endothelium-derived nitric oxide on skin and digital blood flow in humans. Am J Physiol 1994; 267: H2087-H2090.
38. Herbert MK, Holzer P. Nitric oxide mediates the amplification by interleuki-1 beta of neurogenic vasodilatation in the rat skin. Eur J Pharmacol 1994; 260: 89-93.
39. Holzer P, Jocic M. Cutaneous vasodilatation induced by nitric oxide evoked stimulation of afferent nerves in the rat. Br J Pharmacol 1994; 112: 1181-1187.
40. Boolell M, Tooke JE. The skin hyperaemic response to local injection of substance P and capsaicin in diabetes mellitus. Diabetic Med 1990; 7: 898-901.
41. Kihara M, Opfer-Gehrking TL, Low PA. Comparison of directly stimulated with axon-reflex-mediated sudomotor responses in human subjects and in patients with diabetes. Muscle-Nerve 1993; 16: 655-660.
42. Lang E, Spitzer A, Claus D, Neundorfer B, Handwerker HO. Stimulation of sudomotor axon-reflex mechanism by charbacol in healthy subjects and patients suffering from diabetic polyneuropathy. Acta Neurol Scand 1995; 91: 251-254.
43. Said C, Slama G, Selva J. Progressive centripetal degeneration of axons in small fibre type diabetic polyneuropathy. Clin Pathol Study Brain 1983; 106: 761.
44. Guy RJC, Clark CA, Malcom PN, Watkins PJ. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia 1985; 28: 131-137.